Tactile Systems Technology, Inc. (TCMD) Stock Analysis & Investment Frameworks

Tactile Systems Technology, Inc. (TCMD) stock analysis on Invetso. Review Tactile Systems Technology, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.

Tactile Systems Technology, Inc. Company Overview

Tactile Systems Technology, Inc. Key Financial Metrics

About Tactile Systems Technology, Inc.

Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.

Tactile Systems Technology, Inc. Investment Frameworks

Invetso analyzes Tactile Systems Technology, Inc. (TCMD) across the following frameworks:

Explore More TCMD Research